Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis Through Toll-Like Receptor 4 Pathways
Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.116.239137
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2017
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)